Freespira

Freespira is a leading provider of medication-free, FDA-cleared digital therapeutic treatments for panic disorder, panic attacks, and post-traumatic stress disorder (PTSD). They offer an at-home treatment program that utilizes a breathing sensor and tablet app to help patients retrain their breathing patterns, addressing the underlying physiological factors of these conditions. Their treatment has been clinically proven to significantly reduce or eliminate symptoms in just 28 days.

Freespira collaborates with a range of partners, including health plans, employers, providers, veterans' organizations, and aggregators, to expand access to their treatment and improve mental health outcomes. They have a strong commitment to innovation and research, actively developing new solutions and sharing their clinical findings to advance the understanding and treatment of anxiety disorders.

Freespira is a company dedicated to providing medication-free, FDA-cleared treatment for panic disorder, panic attacks, and PTSD. They offer a digital therapeutic solution that addresses the underlying physiological factors of these conditions, particularly breathing dysregulation, using a 28-day at-home program. Their mission is to help millions of Americans who suffer from panic disorder and PTSD find relief, improve their quality of life, and stay out of emergency rooms.

Freespira promotes a culture of innovation and collaboration focused on providing accessible and effective solutions for anxiety and PTSD. The company is driven by a mission to empower individuals with the tools and support to overcome their challenges and live healthier, more fulfilling lives. They value empathy, compassion, and a commitment to making a real difference in the lives of those who suffer from panic disorder and PTSD.

Freespira's website does not contain information about their specific approach to diversity, equity and inclusion. NONE